Kevin David Costa

Corporate Officer/Principal en Icahn School of Medicine at Mount Sinai .

Consumer Services

Health Technology

Perfil

Kevin David Costa was the founder and had founded Novoheart Holdings, Inc. in 1964 where he held the title of Chief Scientific Officer.
Currently, he is the Director-Cardiovascular Cell & Tissue Engineering at Icahn School of Medicine at Mount Sinai since 2009.
Previously, he worked as an Associate Professor at The Trustees of Columbia University in The City of New York.
Dr. Costa received his undergraduate and graduate degrees from Boston University and his doctorate from the University of California San Diego.

Cargos activos de Kevin David Costa

Empresas	Cargo	Inicio
Icahn School of Medicine at Mount Sinai	Corporate Officer/Principal	01/01/2009

Todos los cargos activos de Kevin David Costa

Antiguos cargos conocidos de Kevin David Costa.

Empresas	Cargo	Fin
The Trustees of Columbia University in The City of New York	Corporate Officer/Principal	-
NOVOHEART HOLDINGS INC.	Fundador	-

Ver el detalle de la experiencia de Kevin David Costa.

Formación de Kevin David Costa.

Boston University	Graduate Degree
University of California San Diego	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kevin David Costa.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Novoheart Holdings, Inc. Novoheart Holdings, Inc. BiotechnologyHealth Technology Novoheart Holdings, Inc. is a global stem cell biotechnology company. It engages in engineering prototypes of bio-artificial human heart tissues and chambers for drug discovery, cardio toxicity screening, diseases modeling and therapeutic applications. The firm products include Human Ventricular Cardiomyocytes (hvCM), Cardiac Anisotropic Sheet (hvCAS), Cardiac Anisotropic Patch (hvCAP), Cardiac Tissue Strip (hvCTS), and novoHeart. The company was founded by Michelle Khine, Kevin Costa and Ronald Li on April 28, 1964 and is headquartered in Vancouver, Canada.	Health Technology